We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Matthew
Harries
Matthew.Harries@nca.nhs.uk
White
Caroline
caroline.white@manchester.ac.uk
Disorders of skin appendages
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
People with hair loss regularly describe difficulties at the start of their journey in securing a diagnosis and treatment, and delays in referral to secondary care. Clinicians frequently struggle to accurately diagnose and measure hair loss over time. Therefore, pathways to secure early treatment, along with accurate and responsive hair loss assessment tools, will benefit alopecia patients by improving diagnostic accuracy, enable effective monitoring and ultimately improve treatment efficacy in this group.
This project is split into two complementary arms:
1) “ETAP” (Early Treatment to prevent Alopecia Progression) aims to better understand whether early identification and treatment of alopecia at first presentation will increase hair re-growth rates and reduce the risk of relapse and disease progression in the longer term.
2) “GAIA” (Generating Artificial Intelligence assisted assessment for Alopecia) aims to generate novel artificial intelligence (AI) assisted assessment to enable early diagnosis and support monitoring of alopecia over time. Our ambition is to design new AI algorithm for objective measurement of hair loss and develop a novel mobile app (“GAIA”) as point-of-care for people with alopecia.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
ETAP • Any other hair loss conditions, not specified in the inclusion criteria • Unable or unwilling to complete the study survey GAIA Medical photographs from patients: • Poor quality photographs / insufficient view • Photographs consented for medical records only. I this situation, additional consent would be required before use of these images
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by NORTHERN CARE ALLIANCE NHS FOUNDATION TRUST and funded by ALOPECIA UK .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 56149
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
